CHRNA7 and acute kidney injury: PNU-282987 is a selective agonist of α7nAchR with high affinity, which can alleviate AKI induced by lipopolysaccharide (LPS), and significantly downregulate systemic levels of tumor necrosis factor-α (TNF-α), interleukin (IL), and IL-1β [22].